spcare.bmj

Integrated palliative care service for Parkinson’s disease in the UK: impact on place of death

Objectives Patients with advanced Parkinson’s disease and related disorders (PDRD) experience significant symptom burden, yet access to specialist palliative care (SPC) is often limited. The Bristol ...
spcare.bmj

Midazolam versus dexmedetomidine: breakthrough use variations—the DREAMS trial secondary analysis

Objectives Patients in the terminal phase may require both regular medications and breakthrough medications for palliative symptom management. Breakthrough dosing can provide an objective measure of ...
spcare.bmj

Urgent need for system reform in future care planning, access to palliative care and care coordination

Improving access to palliative care for all who need it has been a Scottish Government priority since 2008 that continues. Significant systemic barriers to realising this aim are well recognised ...
spcare.bmj

Psoas muscle indices, visceral fat distribution, inflammatory markers and 90-day mortality in palliative medicine: retrospective cohort study

Objective The aim of this study is to evaluate the prognostic value of CT-based body composition parameters (skeletal muscle quantity and muscle quality), fat distribution, Global Leadership ...
spcare.bmj

Implementing a digital advance care plan in practice: a qualitative study of healthcare professionals’ perspectives

Objectives This study examines healthcare professionals’ (HCPs’) experiences of implementing digital advance care plans (DACPs) to support information-sharing and decision-making in end-of-life care ...
spcare.bmj

Pharmacological prevention of oxaliplatin-induced peripheral neuropathy in gastrointestinal cancer: systematic review

Background Oxaliplatin-induced peripheral neuropathy (OIPN) is a common and debilitating toxicity in gastrointestinal (GI) cancer patients. Current guidelines lack consensus on pharmacological ...
spcare.bmj

Global palliative care cannot wait another generation: delivering on the Universal Health Coverage (SDGs) by 2030

Universal Health Coverage (UHC) is a cornerstone of the Sustainable Development Goals (SDGs).1 With <5 years remaining until the SDGs’ 2030 deadline, global health is at a critical juncture. While the ...
spcare.bmj

Informal caregiver burden and psychological distress among primary family caregivers of patients who had a stroke

Objectives The burden of caregiving on families is significantly increased in neurodegenerative diseases such as stroke, where medical care is required along with physical limitations. This research ...
spcare.bmj

How can we deliver equitable, evidence-based breathlessness care for all?

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
spcare.bmj

Drug Burden Index in older palliative care inpatients: a medication safety retrospective cohort study

Objectives Polypharmacy can increase symptom burden and reduce quality of life in palliative care patients. The Drug Burden Index (DBI) measures patients’ exposure to anticholinergic and sedative ...
spcare.bmj

Assisted dying: what are the implications for the medical workforce?

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
spcare.bmj

Advance care plans in parkinsonism: cross-sectional study within a randomised controlled trial

Objectives The importance of advance care planning in parkinsonism is increasingly recognised. Existing evidence shows plans are infrequent in this population. Little is known about the details of the ...